Cerebral Venous Sinus Thrombosis as an Initial Presentation of Nephrotic Syndrome: A Case Report.
Yassir BallaAbdullahi Said HashiAhmed Adam OsmanMohamed Sheikh HassanEren MutluPublished in: Vascular health and risk management (2024)
Cerebral sinovenous thrombosis (CSVT) encompasses a spectrum of disorders involving thrombosis of the cerebral venous system. As shown by previous epidemiological studies, the prevalence of cerebral sinovenous thrombosis is 4-7 cases per million people. Nephrotic syndrome was very rarely associated with thrombosis cerebral veins or sinuses. Hypercoagulability and thrombotic complications in nephrotic syndrome are most commonly seen in deep veins of the lower extremities and renal veins. Our case highlights a unique scenario in which cerebral sinovenous thrombosis was the initial presentation of nephrotic syndrome in a patient that was not an important past medical or surgical problem. The patient was brought to the emergency department with severe headache, vomiting, altered mental status, and generalized body swelling. Laboratory results showed proteinuria, hypoalbuminemia and hyperlipidemia. Non-contrast brain CT demonstrated hemorrhagic venous infarct associated with vasogenic edema. A subsequent brain MR venogram demonstrated occlusion of superior sagittal and right transverse sinuses. She was managed with low molecular weight heparin and intervenous corticosteroids then shifted to rivaroxaban and oral steroids, respectively, which resulted in massive clinical improvement and resolution of thrombus.
Keyphrases
- pulmonary embolism
- subarachnoid hemorrhage
- cerebral ischemia
- emergency department
- inferior vena cava
- case report
- healthcare
- risk factors
- magnetic resonance
- venous thromboembolism
- computed tomography
- contrast enhanced
- white matter
- acute myocardial infarction
- acute coronary syndrome
- magnetic resonance imaging
- type diabetes
- cerebral blood flow
- heart failure
- adipose tissue
- left ventricular
- blood brain barrier
- atrial fibrillation
- metabolic syndrome
- percutaneous coronary intervention
- coronary artery disease
- single molecule
- growth factor
- dual energy